Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Coughs Up $40 M for Option on Nabi's Late-Stage Smoking Vaccine NicVAX

Nov 16 2009

• By Alex Lash

Related Content

Infectious Opportunity? Nabi Biopharma Sells Staph A Vaccine To Glaxo For $46M

Aug 07 2009

Nabi Sells Biologics Business To German Plasma Protein Firm Biotest

Sep 11 2007

Pfizer’s Loss Could Be Nabi’s Gain In Stop-Smoking Space

May 27 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window